All products and services are For Research Use Only and CANNOT be used in the treatment or diagnosis of disease.
CAT | Product Name | Target Species | Antibody Clone | Antibody Host | Receptor Construction | Vector Type | Targeting Cell Type | CAR Vector Type | Inquiry & Datasheet |
XS-0822-YF1327 | Anti-Human CD32A (XW-407) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-407 | Mouse | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF1328 | Anti-Human CD32A (XW-408) h(CD28-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-408 | Human | scFv-CD28-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2247 | Anti-Human CD32A (XW-407) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-407 | Mouse | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF2248 | Anti-Human CD32A (XW-408) h(CD28-41BB-CD3ζ) CAR IVT Plasmid, pCARIVT | Human | XW-408 | Human | scFv-CD28-41BB-CD3ζ | In Vitro Transcription (IVT) Vector | |||
XS-0822-YF8650 | TS-Fluc Anti-Human CD32A scFv (XW-407) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-407 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF8651 | TS-Fluc Anti-Human CD32A scFv (XW-408) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-408 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF9059 | TS-Fluc Anti-Human CD32A scFv (XW-407) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-407 | Mouse | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9060 | TS-Fluc Anti-Human CD32A scFv (XW-408) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-408 | Human | 7H-YB-Fluc-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9468 | TS-Fluc Anti-Human CD32A scFv (XW-407) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-407 | Mouse | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9469 | TS-Fluc Anti-Human CD32A scFv (XW-408) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-408 | Human | 7H-YB-Fluc-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF9877 | TS-IL15 SA Anti-Human CD32A scFv (XW-407) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-407 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF9878 | TS-IL15 SA Anti-Human CD32A scFv (XW-408) CD28-CD3ζ CAR, pCDCAR1 | Human | XW-408 | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-CD3ζ | Lentiviral vector | |||
XS-0822-YF10286 | TS-IL15 SA Anti-Human CD32A scFv (XW-407) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-407 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10287 | TS-IL15 SA Anti-Human CD32A scFv (XW-408) 41BB-CD3ζ CAR, pCDCAR1 | Human | XW-408 | Human | 7H-YB-IL15 SA-EF1a-scFv-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10695 | TS-IL15 SA Anti-Human CD32A scFv (XW-407) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-407 | Mouse | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-0822-YF10696 | TS-IL15 SA Anti-Human CD32A scFv (XW-408) CD28-41BB-CD3ζ CAR, pCDCAR1 | Human | XW-408 | Human | 7H-YB-IL15 SA-EF1a-scFv-CD28-41BB-CD3ζ | Lentiviral vector | |||
XS-1122-YF2247 | Anti-CD32A TCR-ABR (scFv-TCRβ, XW-407) CAR Plasmid, pCDCAR1 | Human | XW-407 | Mouse | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF2248 | Anti-CD32A TCR-ABR (scFv-TCRβ, XW-408) CAR Plasmid, pCDCAR1 | Human | XW-408 | Human | scFv-TCRβ | Lentiviral vector | T Cell | ||
XS-1122-YF3167 | Anti-CD32A TCR-ABR (scFv-CD3γ, XW-407) CAR Plasmid, pCDCAR1 | Human | XW-407 | Mouse | scFv-CD3γ | Lentiviral vector | T Cell | ||
XS-1122-YF3168 | Anti-CD32A TCR-ABR (scFv-CD3γ, XW-408) CAR Plasmid, pCDCAR1 | Human | XW-408 | Human | scFv-CD3γ | Lentiviral vector | T Cell |
The latest newsletter to introduce the latest breaking information, our site updates, field and other scientific news, important events, and insights from industry leaders
LEARN MORE NEWSLETTERCellRapeutics™ In Vivo Cell Engineering: One-stop in vivo T/B/NK cell and macrophage engineering services covering vectors construction to function verification.
LEARN MORE SOLUTIONSilence™ CAR-T Cell: A novel platform to enhance CAR-T cell immunotherapy by combining RNAi technology to suppress genes that may impede CAR functionality.
LEARN MORE NOVEL TECHNOLOGYCanine CAR-T Therapy Development: From early target discovery, CAR design and construction, cell culture, and transfection, to in vitro and in vivo function validation.
LEARN MORE SOLUTION